Speakers of Redox Medicine 2024

Keynote Day 1Miria Ricchetti 1
Redox Medicine: A Biologist Point of View 
Miria Ricchetti, Institut Pasteur, France
Bruce Freeman 1Keynote Day 2
Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development
Bruce Freeman, University of Pittsburgh, USA
Martin BergoAntioxidants Stimulate Blood Flow in Tumors
Martin O. Bergo, Karolinska Institutet, Sweden
Mario D. Cordero 1Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling
Mario D. Cordero, Universidad Pablo de Olavide, Spain
Christel MarquetteRegulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
Christel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France
Zaher El Beck 1Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner
Zaher El Beck, Karolinska Institutet and Uppsala University, Sweden
Tamara TominMetabolic Regulation by Redox Signaling in the Heart
Tamara Tomin, Technical University of Wien, Austria
Laurent ChatreThe Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism Nexus
Laurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France
Roberta RizzaNADH: The Redox Sensor in Aging-Related Disorders
Roberta Rizzo, Università degli Studi di Ferrara, Italy
Andrew CumpsteyRedox Implications of Supplementary Oxygen during Major Abdominal Surgery
Andrew Cumpstey, University of Southampton, United Kingdom
Daniel Vaiman 2 updatedNew Insights into the Impact of Oxidative Stress in Hypertensive Diseases of Pregnancy
Daniel Vaiman, DR1 INSERM, Institut Cochin, France
Carole Nicco 1Redox Medicine 2024: Biomarkers
Carole Nicco, President of Redox Medicine Society
Sayuri Miyamoto 1Identifying Oxidized Lipids in Neurodegenerative Diseases
Sayuri Miyamoto, University of São Paulo, Brazil
Jumana SalehExploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to Severity
Jumana Saleh, Sultan Qaboos University, Oman
Radia TamaratRedox, Radiotherapy and Biomarkers
Radia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France
Jeffrey A. Johnson 1Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases
Jeffrey A. Johnson, University of Wisconsin, USA
George M. SpyrouDrug repurposing on Alzheimer's Disease & NRF2 Modulation 
George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus
Duncan Emerton 1Pharma’s Search for Redox-Modulating Therapeutics
Duncan Emerton, Vice-President of Citeline, United Kingdom
Antonio Vila-CoroHow to Develop a Drug – From Preclinical to Clinical
Antonio Vila-Coro, IQVIA, Spain
Stéphane MouchabacArtificial Intelligence in NeuroInflammation, Biomarkers and Redox Medicine
Stéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris 
Maxime BaratArtificial Intelligence & Algorithms: Applications in Redox Medicine & Radiology
Maxime Barat, Université Paris Cité, Hôpital Cochin, France

Scientific News

  • 1
  • 2
Prev Next

read all news